Join the Oncology Voice Network. Join for Free
The ULTIMATE Checklist for New MSLs
MSL Medical Science Liaison Samantha Buckley KOL meetings MSL certification

The ULTIMATE Checklist for New MSLs


Share This Article


Summary

In this episode, Samantha Buckley discusses her journey from clinical pharmacy to becoming an MSL, highlighting the value of personalized cover letters and MSL certification. She delves into territory mapping, strategic planning, and the art of relationship-building as key components of the MSL role. Samantha emphasizes the importance of effective KOL meetings and the insights they provide. She also touches on cross-functional collaboration within Medical Affairs and shares the rewarding aspects of being an MSL. The episode concludes with encouragement for aspiring MSLs and closing remarks.

My guest this week is Samantha Buckley, PharmD. Medical Science Liaison at SOBI who discusses the ultimate checklist for new MSLs.

Learn more about…

πŸ‘‰ The ONE differentiating factor to her MSL job search success
πŸ‘‰ What is day one like for an MSL
πŸ‘‰ Training and certification
πŸ‘‰ The ART of MSLing
πŸ‘‰ Prep for initial KOL meetings

Click for Source
MSL, Medical Science Liaison, Samantha Buckley, KOL meetings, MSL certification

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
The Struggle With KOL Access in Todays World
Partner Avatar MSL Talk: Tom Caravela, Carsten Schnatwinkel, Jeanna Cooper

The Struggle With KOL Access in Todays World

Podcast
Surround to Succeed: Building a Motivational Network
Partner Avatar MSL Talk: Tom Caravela, Sarah Snyder

Surround to Succeed: Building a Motivational Network

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts KΓ₯gedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Podcast
MSL Career Options: The transition from Field Medical to Medical Director
Partner Avatar MSL Talk: Tom Caravela, Josh Corriveau

MSL Career Options: The transition from Field Medical to Medical Director

Article
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
OVN Avatar Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth

Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials

Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Explore OVN